Navigation Links
Blood Banking And Blood Products - Global Strategic Business Report
Date:11/11/2013

DUBLIN, November 11, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/vbs28l/blood_banking_and) has announced the addition of the "Blood Banking And Blood Products - Global Strategic Business Report" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

This report analyzes the worldwide markets for Blood Banking and Blood Products in US$ Million by the following Product Segments: Blood Components and Plasma Products (Whole Blood & Cellular Components, & Plasma Fractions), and Equipment, Blood Tests and Other Consumables (Includes blood screening and related QC function, but excludes patient diagnosis). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets.

The report profiles 232 companies including leading blood banks such as AABB, Americas Blood Centers, American Red Cross, Canadian Blood Services, Japan Red Cross, National Blood Foundation, and New York Blood Center. Some of the leading players in Blood Bank Technology & Supplies also discussed in this report include Beckman Coulter Inc., Becton Dickinson and Company, BioMerieux SA, CSL Behring LLC, Daxor Corporation, Fenwal Inc., Gen-Probe, Inc., Haemonetics Corp, Hemagen Diagnostics Inc., Immucor Inc., Kawasumi Laboratories, Inc., Novartis Vaccines and Diagnostics, Inc., Terumo Corporation, Terumo BCT Inc., ThermoGenesis Corp., and Velico Medical, Inc. Leading Players discussed under the Plasma Fractionation segment include Baxter International Inc., Beijing Tiantan Biological Products Co., Ltd., Bharat Serums, Bio Products Laboratory, Biotest AG, CSL Limited, Grifols, S.A, Guizhou Taibang Biological Products Co., Ltd., Huanlan Biological Engineering Inc., Kedrion S.p.A., Laboratoire Français du Fractionnement et des Biotechnologies, Octapharma AG, OMRIX Biopharmaceuticals Ltd., Shanghai RAAS Blood Products Co., Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., and Sanquin. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.


Key Topics Covered:


I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

2. MARKET TRENDS & ISSUES

3. PRODUCT OVERVIEW

4. BLOOD COLLECTION METHODS

5. THE CHANGING LANDSCAPE OF TRANSFUSION TECHNOLOGIES & TESTS

6. BLOOD TRANSFUSION: THE PROCESS, TESTS/TECHNOLOGIES

7. ALTERNATIVES TO BLOOD TRANSFUSION: A REAL THREAT TO THE INDUSTRY

8. BLOOD SUBSTITUTES

9. PRODUCT INNOVATIONS/LAUNCHES IN RECENT PAST - A PERSPECTIVE BUILDER

10. PRODUCT APPROVALS

11. PRODUCT APPROVALS IN THE RECENT PAST

12. RECENT INDUSTRY ACTIVITY

13. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER

14. FOCUS ON SELECT GLOBAL PLAYERS

15. GLOBAL MARKET PERSPECTIVE

III. MARKET

1. THE UNITED STATES

2. CANADA

3. JAPAN

4. EUROPE

4a. FRANCE

4b. GERMANY

4c. ITALY

4d. THE UNITED KINGDOM

4e. SPAIN

4f. RUSSIA

4g. REST OF EUROPE

5. ASIA-PACIFIC

6. LATIN AMERICA

7. REST OF WORLD


IV. COMPETITIVE LANDSCAPE


Companies Mentioned
- AABB-American Association Of Blood Banks (USA)
- Abbott Laboratories (USA)
- Bard Access Systems, Inc. (USA)
- Bristol-Myers Squibb Company (USA)
- California Cryobank (USA)
- Cryo-Cell International, Inc. (USA)
- Cryocord Sdn. Bhd. (Malaysia)
- Florida's Blood Centers (USA)
- Green Cross America Plasma (USA)
- Heinz Herenz Medizinalbedarf GmbH (Germany)
- Hualan Biological Engineering, Inc. (China)
- JMS North America Corporation (USA)
- LifebankUSA (USA)
- New England Cord Blood Bank, Inc. (USA)
- OctaPharma AG (Switzerland)
- Qorpak (USA)
- Smiths Group PLC (UK)
- Smiths Medical (South Africa) Pty., Ltd. (South Africa)
- Teleflex Medical (USA)
- The Texas Cord Blood Bank (USA)
- Trinity Biotech PLC (Ireland)
- ViaCord (USA)


For more information visit http://www.researchandmarkets.com/research/vbs28l/blood_banking_and

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Worldwide Vital Signs Monitoring Market Report 2013-2018: Blood Pressure Monitoring Devices, Pulse Oximeters and Temperature Monitoring Devices
2. Seventh Sense Biosystems Receives CE Mark Approval for its Touch Activated Phlebotomy Blood Collection and Testing System
3. Epaned, a Liquid Form of Enalapril for Children and Adults with High Blood Pressure, Now Available by Prescription
4. Measuring Blood Sugar With Light
5. Blood Pressure Management Changed on Global Level with OSTARs 3SI Interpretive Blood Pressure Algorithm
6. Exosome Diagnostics Enters Collaboration Agreement with Lilly for Exosome Blood-Based Biomarker Discovery
7. Automated Telephone Calls Improve Blood Pressure Control
8. Diabetes Technology Society Outlines Potential Post-clearance Surveillance Program To Address Inaccuracy Of Blood Glucose Monitors
9. National Diabetes Volunteer Leadership Council (NDVLC) Urges FDA to Enforce Stringent Accuracy Standards for Blood Glucose Monitoring Systems
10. Simultaneous Applications Submitted to FDA and EMA for Siltuximab for the Treatment of Multicentric Castleman Disease, a Rare Blood Disorder
11. Study Demonstrates Glysure Systems Ability to Accurately Measure Blood Glucose Levels in the ICU
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... 27, 2017 The National University of ... data analytics company, signed a Memorandum of Understanding ... delivery in the region. Under ... Research and Technology (BIGHEART) at NUS and Holmusk ... related to healthcare IT and medical device development. ...
(Date:3/27/2017)... , March 27, 2017 ... specialty clinical-stage pharmaceutical company specializing in the development of ... public offering in the United States ... each ADS representing 40 ordinary shares of the ... In addition, Therapix has granted the underwriters a ...
(Date:3/27/2017)... Calif. , March 27, 2017  Cryoport, Inc. ... that it intends to offer shares of common stock ... registration statement on file with the Securities and Exchange ... and other conditions, and there can be no assurance ... completed, or as to the actual size or terms ...
Breaking Medicine Technology:
(Date:3/28/2017)... , ... March 28, 2017 , ... The Radiology ... FRBMA, has begun to serve as its new executive director. Mr. Still was selected ... Search Committee. , “Bob, as he is known to our members, has been ...
(Date:3/28/2017)... ... March 28, 2017 , ... With less than 10,000 dermatologists in the United ... can be limited while the desire to conquer breakouts and eliminate skincare stress is ... every customer online, today released its inaugural survey on the State of Acne in ...
(Date:3/28/2017)... ... March 28, 2017 , ... A minimally invasive ... “perfect smile.” The National Association of Dental Laboratories (NADL) is informing dentists about ... aware of when utilizing dental laboratories and technicians that create these veneers. ...
(Date:3/28/2017)... ... , ... With expansion and efficiency in mind, Patten Seed Company completed relocation ... plant opened in Marshallville in 2006, and a bagging and shipping facility has been ... of Patten Seed operations to the Middle Georgia location from their previous home in ...
(Date:3/28/2017)... ... ... “A Prophets Bones”: a thrilling adventure that reveals the mystery of Kevin’s purpose. “A Prophets ... parents and teachers had asked of him that he had neglected to do, but this ... Almighty Creator. There were some who would have felt themselves to be special and better ...
Breaking Medicine News(10 mins):